Posted on September 24th, 2010 by
The National Cancer Institute (NCI) has awarded five-year, multi-institution grants in continued support of its Alliance for Nanotechnology in Cancer program. The Alliance is engaged in efforts to leverage the specific advantages of nanotechnology to improve the way we diagnose, treat, and prevent cancer. Researchers involved in the program have developed a host of novel technologies, with several of them undergoing commercialization and clinical trials. Given the progress to date, the NCI approved a second phase of the program with an investment of approximately $30 million per year for the next five years. Link
You must be logged-in to the site to post a comment.